Phoenixville, PA, United States of America

Mark R Player

USPTO Granted Patents = 39 (Patent Applications = 5)

CIPO Patents = 3 (Patent Applications = 2)

EPO Patents = 6 (Patent Applications = 6)

Average Co-Inventor Count = 5.6

ph-index = 6

Forward Citations = 241(Granted Patents)

Location History:

Gaithersburg, MD (US) (2001)
Phoenixville, PA (US) (2005 - 2021)

Company Filing History:

29 out of 2,078

Janssen Pharmaceutica Nv

patents

3 out of 76

3-dimensional Pharmaceuticals, Inc.

patents

3 out of 276

Boehringer Ingelheim Pharmaceuticals, Inc.

patents

4. 2 out of 363

Ortho-mcneil Pharmaceutical Corp.

patents

5. 2 out of 832,843

Other

patents

Years Active: 2001-2021

Loading Chart...

39 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10988433 - Cyclohexyl GPR40 agonists for the treatment of type II diabetes (2021-04-27),

2. 10662170 - Substituted benzothiophenyl derivatives as GPR40 agonists for the treatment of type II diabetes (2020-05-26),

3. 10131648 - Substituted benzothiophenyl derivatives as GPR40 agonists for the treatment of type II diabetes (2018-11-20),

4. 10106553 - Substituted benzothiophenyl derivatives as GPR40 agonists for the treatment of type II diabetes (2018-10-23),

5. 9920040 - GPR40 agonists for the treatment of type II diabetes (2018-03-20),

6. 9908873 - GPR40 agonists for the treatment of type II diabetes (2018-03-06),

7. 9856245 - GPR40 agonists for the treatment of type II diabetes (2018-01-02),

8. 9790198 - Substituted benzothiophenyl derivatives as GPR40 agonists for the treatment of type II diabetes (2017-10-17),

9. 9718820 - Substituted aza-bicyclic imidazole derivatives useful TRPM8 receptor modulators (2017-08-01),

10. 9688642 - Substituted pyrazines as GPR40 agonists (2017-06-27),

11. 9409915 - Substituted aza-bicyclic imidazole derivatives useful as TRPM8 receptor modulators (2016-08-09),

12. 9249163 - PDE10a inhibitors for the treatment of type II diabetes (2016-02-02),

13. 9193736 - PDE 10a inhibitors for the treatment of type II diabetes (2015-11-24),

14. 9067898 - Isothiazole derivatives as GPR120 agonists for the treatment of type II diabetes (2015-06-30),

15. 9023846 - Substituted AZA-bicyclic imidazole derivatives useful as TRPM8 receptor modulators (2015-05-05),

Title: The Inventor Mark R Player: Pioneering Innovations in Phoenixville

Introduction: Mark R Player is a distinguished inventor based in Phoenixville, Pennsylvania, known for his groundbreaking contributions to various industries.

Latest Patents: Mark R Player holds several patents in the fields of technology, healthcare, and consumer goods, showcasing his versatility and ingenuity.

Career Highlights: With a career spanning over two decades, Mark R Player has consistently pushed the boundaries of innovation, leading to the development of cutting-edge solutions that have transformed the way we live and work.

Collaborations: Throughout his career, Mark R Player has collaborated with leading companies, research institutions, and universities to bring his ideas to life, demonstrating his ability to work across disciplines and industries.

Conclusion: Mark R Player's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors, making him a true pioneer in the world of technology and beyond.

This text is generated by artificial intelligence and may not be accurate.